SecSonar.com

HUTCHMED (China) Limited (HCM)

HUTCHMED (China) Limited at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

HUTCHMED (China) Limited (HCM) is a Drug Manufacturers - Specialty & Generic company based in HK with a market capitalization of $2B. Revenue declined 12.7% year-over-year and free cash flow was negative at -$79M. This page tracks HCM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

HK · 1.81K employees · IPO Mar 16, 2016

Valuation

Valuation & price

$11.71 · as of May 26, 2026 · -39.1% vs 52w high

4.5

P/E ratio

Latest-FY diluted EPS

1.61

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$19.21$14.60$9.99Jul 25Dec 25Jul 26Jul 7, 25$15.42Jul 9, 25$16.30Jul 11, 25$16.04Jul 15, 25$16.56Jul 17, 25$17.52Jul 21, 25$17.74Jul 23, 25$17.57Jul 25, 25$17.61Jul 29, 25$19.21Jul 31, 25$17.78Aug 4, 25$17.28Aug 6, 25$17.93Aug 11, 25$15.48Aug 13, 25$16.00Aug 15, 25$16.45Aug 19, 25$16.21Aug 21, 25$16.11Aug 25, 25$15.93Aug 27, 25$14.96Aug 29, 25$15.01Sep 3, 25$15.27Sep 5, 25$15.97Sep 9, 25$16.05Sep 11, 25$16.37Sep 16, 25$17.44Sep 18, 25$17.45Sep 22, 25$16.66Sep 24, 25$15.88Sep 26, 25$15.64Sep 30, 25$15.75Oct 2, 25$16.12Oct 6, 25$16.21Oct 8, 25$16.39Oct 10, 25$15.08Oct 14, 25$15.11Oct 16, 25$15.40Oct 21, 25$15.20Oct 23, 25$15.04Oct 27, 25$14.86Oct 29, 25$14.71Oct 31, 25$14.68Nov 4, 25$15.44Nov 6, 25$15.45Nov 10, 25$15.09Nov 12, 25$15.28Nov 14, 25$15.08Nov 18, 25$14.66Nov 20, 25$14.18Nov 25, 25$14.26Nov 28, 25$14.42Dec 2, 25$14.26Dec 4, 25$14.16Dec 8, 25$14.04Dec 10, 25$13.78Dec 12, 25$13.42Dec 16, 25$13.19Dec 18, 25$13.35Dec 22, 25$13.18Dec 24, 25$13.52Dec 29, 25$13.40Jan 2, 26$13.65Jan 6, 26$13.75Jan 8, 26$14.77Jan 12, 26$14.93Jan 14, 26$15.30Jan 16, 26$16.05Jan 21, 26$15.85Jan 23, 26$15.31Jan 27, 26$15.24Jan 29, 26$15.25Feb 2, 26$14.56Feb 4, 26$14.78Feb 9, 26$14.89Feb 11, 26$15.11Feb 13, 26$14.76Feb 18, 26$15.10Feb 20, 26$15.29Feb 24, 26$15.08Feb 26, 26$14.72Mar 2, 26$13.90Mar 4, 26$13.65Mar 6, 26$13.85Mar 10, 26$13.89Mar 12, 26$14.19Mar 17, 26$14.30Mar 19, 26$13.82Mar 23, 26$14.00Mar 25, 26$14.15Mar 27, 26$13.81Mar 31, 26$14.96Apr 2, 26$15.42Apr 7, 26$15.39Apr 9, 26$15.16Apr 13, 26$15.28Apr 15, 26$15.30Apr 17, 26$15.74Apr 22, 26$14.56Apr 24, 26$14.00Apr 28, 26$13.59Apr 30, 26$13.44May 4, 26$13.22May 6, 26$13.43May 8, 26$13.13May 12, 26$12.67May 14, 26$12.69May 18, 26$11.95May 20, 26$11.91May 22, 26$11.99May 28, 26$11.23Jun 1, 26$11.40Jun 3, 26$11.31Jun 5, 26$10.87Jun 9, 26$10.63Jun 11, 26$10.68Jun 15, 26$10.83Jun 17, 26$10.12Jun 22, 26$9.99Jun 24, 26$10.27Jun 26, 26$10.17Jul 2, 26$11.44
$9.9952-week range$19.21
Loading valuation history…

Fundamentals

Key fundamentals

$2B

Market cap

-12.7%

Revenue growth (YoY)

38.7%

Gross margin

-$79M

Free cash flow (USD)

-$1.3B

Net debt

Net cash position

0.3%

Share dilution

4/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$216.1MFY 2017$241.2MFY 2018$214.1MFY 2019$204.9MFY 2020$228.0MFY 2021$356.1MFY 2022$426.4MFY 2023$838.0MFY 2024$630.2MFY 2025$550.0M
$216.1M$550M

Free cash flow by year

2016 → 2025

FY 2016$-13.9MFY 2017$-14.0MFY 2018$-39.2MFY 2019$-89.5MFY 2020$-81.6MFY 2021$-221.0MFY 2022$-305.3MFY 2023$186.6MFY 2024$-17.4MFY 2025$-79.0M
-$13.9M-$79M

Gross margin by year

2021 → 2025

FY 202127.5%FY 202227.0%FY 202354.1%FY 202444.6%FY 202538.7%
27.5%38.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 25, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingRegulatory UpdateJul 2, 2026Filing
  • Annual reportAnnual Report FiledJun 30, 2026Filing
  • 6-K filingBlocklisting Six Monthly ReturnJun 29, 2026Filing
  • 6-K filingPivotal Phase II Data HighlightedJun 25, 2026Filing
  • 6-K filingPhase III Data PresentationJun 12, 2026Filing
  • 6-K filingBlock Admission ApplicationJun 5, 2026Filing
  • 6-K filingClinical Data PresentationMay 22, 2026Filing
  • 6-K filingNMPA Approval AnnouncementMay 21, 2026Filing
  • Annual reportAnnual Report FiledMay 12, 2026Filing
  • 6-K filingTotal Voting RightsApr 30, 2026Filing

Questions

Frequently asked questions

What is HUTCHMED (China) Limited's market cap?

HUTCHMED (China) Limited (HCM) has a market capitalization of $2B.

What is HCM's P/E ratio?

HCM trades at a price-to-earnings ratio of 4.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is HCM's price-to-book (P/B) ratio?

HCM trades at 1.61 times book value per share.

When did HUTCHMED (China) Limited last report earnings?

HCM last reported earnings on June 25, 2026; the next date is not yet scheduled.

Are insiders buying HCM stock?

SEC Form 4 filings show no open-market insider buys at HUTCHMED (China) Limited in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

BHC

Bausch Health Companies Inc.

$2B

ANIP

ANI Pharmaceuticals, Inc.

$1.8B

PRGO

Perrigo Company plc

$1.6B

HROW

Harrow Health, Inc.

$1.3B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

PAHC

Phibro Animal Health Corporation

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.